Alpha 1 Antitrypsin therapy in patients with Alpha 1 Antitrypsin deficiency: perspectives from a registry study and practical considerations for self-administration during the COVID-19 pandemic

The challenges of providing alpha 1 antitrypsin therapy during the COVID-19 pandemic and the potential considerations for its implementation thereafter

Saved in:

Bibliographic Details
Main Authors:	Herth, Felix (Author) , Sandhaus, Robert A. (Author) , Turner, Alice M. (Author) , Sucena, Maria (Author) , Welte, Tobias (Author) , Greulich, Timm (Author)
Format:	Article (Journal)
Language:	English
Published:	1 November 2021
In:	The International journal of chronic obstructive pulmonary disease Year: 2021, Volume: 16, Pages: 2983-2996
ISSN:	1178-2005
DOI:	10.2147/COPD.S325211
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2147/COPD.S325211 Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/alpha-1-antitrypsin-therapy-in-patients-with-alpha-1-antitrypsin-defic-peer-reviewed-fulltext-article-COPD
Author Notes:	Felix JF Herth, Robert A. Sandhaus, Alice M. Turner, Maria Sucena, Tobias Welte, Timm Greulich

Description
Summary:	The challenges of providing alpha 1 antitrypsin therapy during the COVID-19 pandemic and the potential considerations for its implementation thereafter
Item Description:	Gesehen am 04.10.2022
Physical Description:	Online Resource
ISSN:	1178-2005
DOI:	10.2147/COPD.S325211